Published June 23, 2015
| Version v1
Patent
Open
Antibody-light fusion products for cancer therapeutics
Contributors
Patent applicants:
Description
Antibody-LIGHT fusion products or conjugates stimulate immunity against tumors and eradicate metastases. Tumor-specific antibodies coupled with LIGHT effectively target metastatic tumors and reduces cancer metastases.
Files
US9061073.pdf
Files
(1.1 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:a1c8e0f5e9cc0b6d4bdd4d33988ec97d
|
1.1 MB | Preview Download |
Additional details
Identifiers
- Patent number
- US 201213563372 A
- Patent application number
- US 9061073 B2
- Other
- oai:uchicago.tind.io:8301
Dates
- Patent filed
-
2012-07-31